Switzerland
Global health initiative, Unitaid, says it is making a $31 million investment to prevent hepatitis C among people who inject drugs, and other at-risk populations such as those in prison.
Marginalized groups are disproportionately affected by the blood-borne disease, which can cause serious liver damage and cancer when left untreated.
Four in ten people who inject drugs and one in four incarcerated individuals have active hepatitis C infections.
Unitaid says there are now highly effective treatments that are affordable in most low- and middle-income countries, where 80 per cent of people with the virus live.
Yet most of them do not have access to care.
Its funding will support efforts to reach these people by incorporating testing and treatment into harm reduction programmes.
At the same time, it will trial the use of two underused products aimed at reducing risks associated with injecting drugs.
Both will be tested in Egypt, India, Kyrgyzstan, Nigeria, South Africa, Tanzania, Ukraine, and Vietnam.
The prevention tools and approaches will also help prevent transmission of other blood-borne diseases including HIV.
Go to video
Paris Olympics: With the opening ceremony minutes away, get to know the African flag bearers
01:30
UN report says around 733 million people globally faced hunger in 2023
Go to video
$35 million investment to boost food security in East Africa
Go to video
Chinese firms eye Morocco as way to cash in on US electric vehicle subsidies
Go to video
Envisioning Africa’s Economic Prospects | Keynote delivered by Dr. Akinwumi A. Adesina
02:20
Designer Imane Ayissi looked East for his latest show in Paris